{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Hamburger Menu
Catalog
Feasibility and Safety of Intravenous Sotalol to I ...
Feasibility and Safety of Intravenous Sotalol to Initiate Oral Sotalol Therapy in Atrial Fibrillation (DASH-AF) - JCEP April 2023
Description
The DASH-AF trial shows that rapid IV sotalol loading in atrial fibrillation/flutter patients for rhythm control is feasible and safe compared with conventional oral loading with significant cost reduction. (Feasibility and Safety of Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients With Atrial Fibrillation [DASH-AF]).
Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC
CME Editor
Kenneth A. Ellenbogen, MD, FACC
Author
Kelvin Bush, MD, FACC
Important Dates
Date of Release: April 24, 2023
Term of Approval/Date of CME/MOC Expiration: April 23, 2024
Summary
Availability:
On-Demand
Expires on Apr 23, 2024
Cost:
FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
×
Feasibility and Safety of Intravenous Sotalol to Initiate Oral Sotalol Therapy in Atrial Fibrillation (DASH-AF) - JCEP April 2023 Course List
Login
User Login
Continue with Google
OR
Login Name/Email
Password
Logging In…
Forgot Password
×
Please select your language
1
English